7 Things You Need to Know About the New Attack on AMA's Billing Codes
The American Medical Association (AMA) has long held a powerful grip on the nation's medical billing system through its proprietary Current Procedural Terminology (CPT) codes. But that grip is now under fire. House Oversight Committee Chair James Comer (R-Ky.) has launched a probe linking the AMA's billing codes to potential fraud, waste, and abuse in federal health programs. This listicle breaks down the key developments, the players involved, and what it means for doctors, patients, and taxpayers. Whether you're a healthcare professional, a policy wonk, or just someone who wants to understand the latest Beltway battle, here are seven things you need to know.
1. What Are CPT Codes and Why Do They Matter?
Current Procedural Terminology (CPT) codes are a uniform system of five-digit numbers used by healthcare providers to bill insurance companies and government programs like Medicare for every service, procedure, or test performed. The AMA developed and owns the copyright to these codes, and it licenses them to payers and providers for a fee—generating tens of millions of dollars annually. In 2023 alone, the AMA earned over $70 million from CPT licensing. These codes are embedded in the backbone of U.S. healthcare billing, meaning any change to them could ripple through the system. Critics argue that the AMA's dual role as both the creator of the codes and a powerful lobby group creates a conflict of interest, especially when the codes influence reimbursement rates and clinical decisions.
2. Who Is James Comer and What Is He Alleging?
Representative James Comer, a Republican from Kentucky, chairs the House Committee on Oversight and Accountability. In early April 2025, Comer sent a letter to the AMA questioning whether its billing code system facilitates fraudulent billing, waste, and abuse—particularly in Medicare and Medicaid. Comer has requested detailed financial records, including how the AMA sets and updates codes, and whether any code changes have been influenced by lobbying from specialty societies or drug companies. He also asked for data on how often codes are misused to inflate payments. While the AMA has defended its system as transparent and evidence-based, Comer's investigation represents the first major congressional challenge to the AMA's monopoly over medical billing codes.
3. The Brian Reid Connection
Before Comer's probe made headlines, drug-pricing policy writer Brian Reid highlighted the issue in his Friday newsletter. Reid noted a peculiar grammatical error—using "health care" as a compound noun—but more importantly, he flagged the AMA's billing codes as a potential source of systemic fraud. Reid's commentary, which STAT's D.C. Diagnosis newsletter sarcastically referenced with a "[sic]" notation, brought the topic to a wider policy audience. It's a classic Beltway echo chamber: a policy nerd's joke about an AP style rule ends up spotlighting a billion-dollar loophole. Reid argued that the AMA's control over codes allows it to quietly steer billions of taxpayer dollars toward certain specialties without adequate oversight—a claim that Comer's investigation will now test.
4. Past Criticisms of the AMA's Billing System
The AMA's CPT codes have faced scrutiny before. In 2021, the Government Accountability Office (GAO) recommended that the Department of Health and Human Services (HHS) reduce its reliance on the AMA for code updates, citing potential conflicts of interest. Consumer advocates have long pointed out that the AMA's committee that decides on new codes is dominated by specialty societies, which may push for codes that boost reimbursement for their members. For instance, the creation of a separate code for a specialized procedure can lead to higher payments, even if the evidence for its effectiveness is weak. The Federal Trade Commission also raised concerns in a 2020 report, noting that the AMA's monopoly on codes could stifle innovation and inflate costs. Comer's investigation builds on these earlier criticisms, but with the added weight of a congressional subpoena power.
5. Potential Financial Impact on Medicare and Taxpayers
If the AMA's billing codes are indeed being manipulated to maximize reimbursement, the cost to taxpayers could be staggering. Medicare alone processes over 1 billion claims each year, each tagged with one or more CPT codes. A small uptick in the relative value assigned to a common code—say, for an office visit or a routine blood test—can mean billions of dollars in additional payments over time. The HHS Office of Inspector General has repeatedly flagged improper payments in Medicare, totaling over $30 billion in 2024 alone. While not all of that is due to CPT code manipulation, the AMA's system provides a plausible mechanism for systematic overbilling. Comer's committee will likely demand data on how the AMA's coding decisions correlate with spending trends.
6. The Political Angle: Why Now?
Comer's attack on the AMA is not happening in a vacuum. Republicans have been ramping up oversight of federal health programs, looking for waste to justify budget cuts. At the same time, the AMA has clashed with the Biden administration over issues like drug price negotiation and telehealth expansion. Some see Comer's move as a political lever to pressure the AMA into supporting GOP priorities. However, the fraud angle is genuinely bipartisan: Democrats have also criticized the AMA's opaque pricing process. Notably, Senator Elizabeth Warren (D-Mass.) has called for federal takeover of the CPT code system. Comer, a Trump ally, may be using the issue to score points with fiscal conservatives while also weakening a powerful Democratic-leaning interest group. The timing also coincides with ongoing debates about physician payment reform, making the AMA a convenient target.
7. What Could Happen Next?
The immediate next step is the AMA's response to Comer's document request. If the organization stonewalls, Comer could issue a subpoena. If the investigation turns up evidence of systematic fraud, it could lead to legislation stripping the AMA of its role in code management—a move that would require creating a new federal agency or transferring authority to HHS. Alternatively, the AMA might preemptively reform its code-setting process to avoid government intervention. Doctors and hospital systems are watching closely: any change could disrupt how they bill for services, potentially affecting reimbursement rates and administrative burdens. For patients, the outcome could mean more accurate billing, but also possible delays as new codes are implemented. One thing is certain: the AMA's billing code monopoly is now firmly in the crosshairs of Congress.
In conclusion, the attack on the AMA's billing codes is more than a political stunt—it's a long-overdue examination of a system that funnels billions of taxpayer dollars through a private organization with little transparency. Whether Comer's investigation leads to real reform or just political theater remains to be seen, but the spotlight is now on the little five-digit numbers that drive American healthcare.